Literature DB >> 2986875

Acetylcholine release from rat atria can be regulated through an alpha 1-adrenergic receptor.

G T Wetzel, D Goldstein, J H Brown.   

Abstract

Isolated superfused rat atria release [3H]acetylcholine when depolarized with 57 mM potassium. The depolarization-induced overflow of [3H]acetylcholine is markedly inhibited by micromolar concentrations of epinephrine and norepinephrine. The alpha 1-selective adrenergic agonist methoxamine also inhibits tritium overflow, but the alpha 2-selective adrenergic agonist clonidine and the beta-adrenergic agonist isoproterenol do not. Prazosin, an selective alpha 1-adrenergic antagonist, blocks adrenergic inhibition of [3H]acetylcholine overflow with a Ki of approximately 0.4 nM. Yohimbine has approximately one-hundredth the potency of prazosin for blocking adrenergic inhibition of [3H]acetylcholine overflow. [3H]Norepinephrine overflow from isolated rat atria is also inhibited by norepinephrine, but this effect is antagonized by yohimbine and not by prazosin. We suggest that the release of acetylcholine from cardiac parasympathetic neurons can be regulated through an alpha 1-adrenergic receptor, and that this mechanism may underly, at least in part, the relative lack of effects of prazosin on heart rate.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986875     DOI: 10.1161/01.res.56.5.763

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  12 in total

Review 1.  Dynamic nonlinear vago-sympathetic interaction in regulating heart rate.

Authors:  K Sunagawa; T Kawada; T Nakahara
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

2.  Effect of alpha-adrenoceptor agonists and antagonists on cholinergic transmission in guinea-pig isolated atria.

Authors:  R E Loiacono; D F Story
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-09       Impact factor: 3.000

Review 3.  Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptides.

Authors:  Julia Shanks; Neil Herring
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-04       Impact factor: 3.619

4.  Phenylethylamine-induced release of noradrenaline fails to stimulate alpha 1-adrenoceptors modulating [3H]-acetylcholine release in rat atria, but activates alpha 2-adrenoceptors modulating [3H]-serotonin release in the hippocampus.

Authors:  S Benkirane; S Arbilla; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

5.  Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro.

Authors:  N Herring; D J Paterson
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

6.  Prejunctional facilitatory alpha 1-adrenoceptors in the rat urinary bladder.

Authors:  G T Somogyi; M Tanowitz; W C de Groat
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

7.  Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors.

Authors:  Eckhard Schwertfeger; Thomas Klein; Oliver Vonend; Vitus Oberhauser; Johannes Stegbauer; Lars Christian Rump
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-22       Impact factor: 3.000

8.  Galanin and neuropeptide Y reduce cholinergic transmission in the heart of the anaesthetised mouse.

Authors:  Margaret A Smith-White; Tiina P Iismaa; Erica K Potter
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

9.  Possible involvement of presynaptic alpha 1-adrenoceptors in the effects of idazoxan and prazosin on 3H-noradrenaline release from tail arteries of SHR.

Authors:  P E Hicks; M Najar; M Vidal; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

10.  Co-transmitter mediated facilitation by sympathetic nerve stimulation of evoked acetylcholine release from the rabbit perfused atria preparation.

Authors:  A Habermeier-Muth; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-02       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.